Spero.jpg
Spero Therapeutics Announces Positive Phase 1 Clinical Data From Potentiator Platform
October 03, 2017 08:00 ET | Spero Therapeutics
CAMBRIDGE, Mass., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc., a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel...
Spero Announces Appointment of Frank Thomas to its Board of Directors and Promotions within Leadership Team
September 06, 2017 08:00 ET | Spero Therapeutics
Cristina Larkin promoted to Chief Operating Officer Timothy Keutzer Promoted to Senior Vice President, Development CAMBRIDGE, Mass., Sept. 06, 2017 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc., a...